Journal of Microbial & Biochemical Technology

Kevin K.W. Wang

Biography

Dr. Wang obtained his Ph.D. in Pharmaceutical Sciences with Distinction from the University of British Columbia in Vancouver in 1989. He is internationally recognized for his original contributions to the fields of CNS disorders-linked proteolytic enzymes, neuroproteomics and disease biomarker discovery. He joined Parke-Davis Pharmaceutical Research (Ann Arbor, MI) in 1991, and following the company's merger with Pfizer Inc. (2000), he became Group Leader of CNS Therapeutics/CNS new targets team and worked on several lead drug candidates. He also co-chaired the Far East Scientific Opportunity Team. In 2002, he became Associate Professor of Psychiatry at the University of Florida (Gainesville, FL), Associate Director of the Center for Traumatic Brain Injury Studies and Director of the Center of Neuroproteomics and Biomarkers Research. In 2002, he co-founded Banyan Biomarkers Inc. (Alachua, Florida). In 2007, he transitioned to Banyan as full-time Chief Scientific Officer and the Center Director of the Center of Innovative Research. In 2011, he rejoined the University of Florida McKnight Brain Institute as Executive Director - the Center for Neuroproteomics and Biomarkers Research /Chief in Translational Research, McKnight Brain Institute to continue to conduct basic and translational research. He is also Chair Professor of the Taipei Medical University and Adjunct Research Professor of Neurology, SUNY-Downstate. Dr. Wang published more than 200 peer-reviewed papers, reviews and book chapters and co-authored eight US patents. He co-edited four books on proteases and neuroproteomics and biomarkers for CNS disorders. He also serves on six international journal’s Editorial Board. Dr. Wang is immediate Past President of the National Neurotrauma Society (USA).    

Research Interest

CNS Injury and protease research, Biomarkers, psychiatric diseases, substance abuse, Neuro-Proteomics, Diagnostics and Therapeutic development, Theranostics